Baxter made a software fix last year after it found pumps werent issuing an occlusion alarm. Now, the devices might issue alarms even when there isnt a blockage.
The pump relaunch isn’t expected to contribute much to this year’s revenue, but could help Becton Dickinson reach its long-term financial goals.
The CMS disclosed add-on payments that will continue in 2024 and named products that received approval under the breakthrough devices pathway.
ImmPrev Bio secures licence for Crohn’s Disease diagnostic tool
Atantares raises $13.9m in pre-Series A funding to develop molecular chips
LightForce Orthodontics raises $80m for 3D printed personalised braces
